海王生物
(000078)
| 流通市值：138.94亿 | | | 总市值：139.19亿 |
| 流通股本：26.26亿 | | | 总股本：26.31亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,071,336,403.32 | 3,063,948,201.93 | 3,275,636,071.84 | 3,456,273,633.71 |
| 交易性金融资产 | 125,939,578.37 | 122,630,346.17 | 123,431,539.47 | 125,433,276.07 |
| 应收票据及应收账款 | 16,113,826,178.68 | 15,958,703,415.71 | 16,402,665,359.5 | 16,219,849,159.83 |
| 其中：应收票据 | 1,044,017,828.98 | 810,849,804.04 | 1,036,126,120.32 | 900,426,597.57 |
| 应收账款 | 15,069,808,349.7 | 15,147,853,611.67 | 15,366,539,239.18 | 15,319,422,562.26 |
| 应收款项融资 | 75,387,213.96 | 59,132,839.22 | 137,880,269.28 | 164,791,057.77 |
| 预付款项 | 294,934,711.68 | 350,382,156.91 | 359,870,313.37 | 317,289,075.05 |
| 其他应收款合计 | 2,355,317,149.98 | 1,775,293,809.31 | 1,833,551,011.83 | 1,822,982,141.21 |
| 应收股利 | 5,613,579.12 | 8,613,579.12 | 8,613,579.12 | 8,613,579.12 |
| 存货 | 3,327,736,910.49 | 3,358,262,412.11 | 3,360,548,554.39 | 3,486,933,682.12 |
| 一年内到期的非流动资产 | - | 2,156,061.33 | 23,213,869.55 | 23,691,517.5 |
| 其他流动资产 | 213,310,702.33 | 245,507,854.36 | 240,323,273.64 | 217,579,675.78 |
| 流动资产合计 | 24,577,788,848.81 | 24,936,017,097.05 | 25,757,120,262.87 | 25,834,823,219.04 |
| 非流动资产: | | | | |
| 长期股权投资 | 194,934,711 | 194,233,433.36 | 193,571,404.87 | 193,570,097.26 |
| 其他权益工具投资 | 122,685,275 | 140,337,205 | 140,337,205 | 140,337,205 |
| 投资性房地产 | 71,172,646.46 | 72,724,847.52 | 72,775,911.78 | 75,059,053.08 |
| 固定资产 | 871,954,535.46 | 891,524,754.46 | 893,228,184.61 | 951,245,081.84 |
| 在建工程 | 106,960,661.36 | 98,513,935.38 | 101,678,874.01 | 84,842,238.45 |
| 使用权资产 | 132,674,537.54 | 131,993,735.98 | 139,491,193.03 | 147,984,570.84 |
| 无形资产 | 322,666,284.36 | 323,306,694.32 | 328,387,122.23 | 367,599,585.5 |
| 开发支出 | 108,127,499.81 | 109,311,425.61 | 105,978,281.29 | 102,657,567.09 |
| 商誉 | 378,703,201.02 | 378,703,201.02 | 378,703,201.02 | 378,703,201.02 |
| 长期待摊费用 | 24,494,666.6 | 25,007,048.26 | 27,514,330.59 | 29,527,172.1 |
| 递延所得税资产 | 331,356,580.22 | 332,559,242.31 | 330,748,306.11 | 357,016,449.49 |
| 其他非流动资产 | 33,161,630.51 | 34,707,484 | 134,441,625.5 | 134,954,723.46 |
| 非流动资产合计 | 2,698,892,229.34 | 2,732,923,007.22 | 2,846,855,640.04 | 2,963,496,945.13 |
| 资产总计 | 27,276,681,078.15 | 27,668,940,104.27 | 28,603,975,902.91 | 28,798,320,164.17 |
| 流动负债: | | | | |
| 短期借款 | 9,924,746,016.69 | 9,772,100,764.26 | 9,929,594,672.21 | 10,023,491,526.1 |
| 交易性金融负债 | 66,968,151.84 | 72,709,111.74 | 72,709,111.74 | 72,709,111.74 |
| 应付票据及应付账款 | 8,351,394,621.32 | 8,431,604,323.38 | 9,046,183,034.22 | 9,102,899,321.3 |
| 其中：应付票据 | 1,102,115,727.8 | 1,298,370,015.82 | 1,863,801,115.35 | 1,759,604,232.21 |
| 应付账款 | 7,249,278,893.52 | 7,133,234,307.56 | 7,182,381,918.87 | 7,343,295,089.09 |
| 预收款项 | 1,361,196.15 | 1,710,178.41 | 1,497,891.91 | 1,272,452.78 |
| 合同负债 | 378,938,902.04 | 389,145,560.64 | 364,629,004.73 | 363,608,592.28 |
| 应付职工薪酬 | 75,217,910.91 | 77,758,646.13 | 80,585,616.47 | 124,119,130.97 |
| 应交税费 | 105,841,294.77 | 102,420,092.86 | 115,703,700.88 | 116,143,353.78 |
| 其他应付款合计 | 4,511,102,680.17 | 4,965,939,557.59 | 5,026,329,199.62 | 5,095,830,356.06 |
| 应付股利 | 89,374,046.85 | 91,550,416.99 | 115,531,902.98 | 143,514,334.91 |
| 一年内到期的非流动负债 | 134,502,370.35 | 126,408,898.04 | 115,943,509.12 | 221,102,388.47 |
| 其他流动负债 | 387,086,806.92 | 451,582,968.15 | 450,009,566.84 | 457,986,589.55 |
| 流动负债合计 | 23,937,159,951.16 | 24,391,380,101.2 | 25,203,185,307.74 | 25,579,162,823.03 |
| 非流动负债: | | | | |
| 长期借款 | 384,670,931.29 | 319,881,486.84 | 356,104,246.7 | 229,796,779.81 |
| 租赁负债 | 87,880,504.85 | 85,104,865.46 | 93,517,968.79 | 99,886,812.32 |
| 长期应付款 | 3,951,725.51 | 4,927,653.45 | 2,546,902.76 | 3,514,443.05 |
| 长期应付职工薪酬 | 181,968.74 | 181,968.74 | 181,968.74 | 181,968.74 |
| 预计负债 | 499,526.81 | 499,526.81 | 499,526.81 | 19,542,639.52 |
| 递延收益 | 4,850,979.67 | 4,879,000 | 8,195,750 | 10,191,377.74 |
| 递延所得税负债 | 12,409,222.74 | 11,846,843.98 | 10,269,895.55 | 12,279,806.4 |
| 非流动负债合计 | 494,444,859.61 | 427,321,345.28 | 471,316,259.35 | 375,393,827.58 |
| 负债合计 | 24,431,604,810.77 | 24,818,701,446.48 | 25,674,501,567.09 | 25,954,556,650.61 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 2,631,123,257 | 2,631,123,257 | 2,631,123,257 | 2,631,123,257 |
| 资本公积 | 2,097,676,745.39 | 2,099,191,174.72 | 2,096,312,097.21 | 2,096,302,343.69 |
| 其他综合收益 | -60,303,050.4 | -60,303,050.4 | -60,303,050.4 | -60,303,050.4 |
| 盈余公积 | 52,141,669.22 | 52,141,669.22 | 52,141,669.22 | 52,141,669.22 |
| 未分配利润 | -2,898,328,763.31 | -2,892,350,063.24 | -2,900,315,987.92 | -2,924,031,770.95 |
| 归属于母公司股东权益合计 | 1,822,309,857.9 | 1,829,802,987.3 | 1,818,957,985.11 | 1,795,232,448.56 |
| 少数股东权益 | 1,022,766,409.48 | 1,020,435,670.49 | 1,110,516,350.71 | 1,048,531,065 |
| 股东权益合计 | 2,845,076,267.38 | 2,850,238,657.79 | 2,929,474,335.82 | 2,843,763,513.56 |
| 负债和股东权益合计 | 27,276,681,078.15 | 27,668,940,104.27 | 28,603,975,902.91 | 28,798,320,164.17 |
| 公告日期 | 2025-10-30 | 2025-08-30 | 2025-04-29 | 2025-04-29 |
| 审计意见(境内) | | | | 标准无保留意见 |